Language

Medicine shortages: Belgium · Page 13

Official notices covering supply interruptions, limited availability and resumed supply. Each notice identifies the product, active ingredient, status and reported period.

Data checked:

1530 notices · Page 13 / 31

← Europe overview

National authority sources: Belgium

Recorded notices include resolved cases. The data check date differs from the modification date of an individual authority notice.

Medicine shortages: Belgium · Page 13

Belgium

Imatinib Teva 100 mg film-coat. tabl. 120 (120 x 1) UD

Nicht verfügbar · Manufacturing delay
Active ingredient: Imatinib

Notice details →
Belgium

Minims Oxybuprocaine Chlorhydrate 4 mg/ml eye drops sol. single-dose cont. 20 x 0.5 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Oxybuprocaine

Notice details →
Belgium

Neurontin 600 mg film-coat. tabl. 90

Nicht verfügbar · Manufacturing delay
Active ingredient: Gabapentin

Notice details →
Belgium

Olanzapine EG 10 mg film-coat. tabl. 98

Nicht verfügbar · Manufacturing delay
Active ingredient: Olanzapine

Notice details →
Belgium

Olmesartan/Amlodipin/HCT Viatris 40 mg - 10 mg - 25 mg film-coat. tabl. 98

Nicht verfügbar · Sonstige
Active ingredient: Olmesartan Medoxomil,Amlodipine,Hydrochlorothiazide

Notice details →
Belgium

Olmesartan/Amlodipine/HCTZ Krka 40 mg - 10 mg - 12.5 mg film-coat. tabl. 98

Nicht verfügbar · Sonstige
Active ingredient: Olmesartan Medoxomil,Amlodipine,Hydrochlorothiazide

Notice details →
Belgium

Olmesartan/Amlodipine/HCTZ Krka 40 mg - 5 mg - 12.5 mg film-coat. tabl. 98

Nicht verfügbar · Sonstige
Active ingredient: Olmesartan Medoxomil,Amlodipine,Hydrochlorothiazide

Notice details →
Belgium

Quetiapine Retard EG 50 mg tabl. prol.-rel. 30

Nicht verfügbar · Increased demand
Active ingredient: Quetiapine

Notice details →
Belgium

Quetiapine Retard EG 50 mg tabl. prol.-rel. 60

Nicht verfügbar · Increased demand
Active ingredient: Quetiapine

Notice details →
Belgium

Rosuvastatin Sandoz 10 mg film-coat. tabl. 100

Nicht verfügbar · Manufacturing delay
Active ingredient: Rosuvastatin

Notice details →
Belgium

Semglee 100 U/ml inj. sol. s.c. pre-filled pen 5 x 3 ml

Available again · Not specified
Active ingredient: Insulin Glargine

Notice details →
Belgium

Solifenacine Teva 10 mg film-coat. tabl. 30

Nicht verfügbar · Manufacturing delay
Active ingredient: Solifenacin

Notice details →
Belgium

Yasmin 0.03 mg - 3 mg film-coat. tabl. 3 x 21

Available again · Not specified
Active ingredient: Ethinylestradiol,Drospirenone

Notice details →
Belgium

Alendronate Viatris 70 mg tabl. 12

Nicht verfügbar · Manufacturing delay
Active ingredient: Alendronic Acid

Notice details →
Belgium

Betahistine Viatris 16 mg tabl. 84

Nicht verfügbar · Manufacturing delay
Active ingredient: Betahistine Dihydrochloride

Notice details →
Belgium

Colistineb 2 10*6 IU nebul. sol. (pwdr.)/inj./inf. sol. (pwdr.) i.v. vial 60 x 2 10*6 IU

Available again · Not specified
Active ingredient: Colistimethate Sodium

Notice details →
Belgium

Daktarin 20 mg/g or. gel 40 g

Nicht verfügbar · Manufacturing delay
Active ingredient: Miconazole

Notice details →
Belgium

Depakine Chrono 500 mg tabl. prol.-rel. 30

Available again · Not specified
Active ingredient: Sodium Valproate,Valproic acid

Notice details →
Belgium

Elvanse 50 mg hard caps. 30

Available again · Not specified
Active ingredient: Dexamfetamine

Notice details →
Belgium

Glucose Sterop 300 mg/ml inf. sol. i.v. amp. 50 x 20 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Glucose Anhydrous

Notice details →
Belgium

Glucose Sterop 500 mg/ml inf. sol. i.v. amp. 10 x 10 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Glucose Anhydrous

Notice details →
Belgium

Glucose Sterop 500 mg/ml inf. sol. i.v. amp. 100 x 10 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Glucose Anhydrous

Notice details →
Belgium

Lipitor 40 mg film-coat. tabl. 100 (100 x 1) UD

Nicht verfügbar · Sonstige
Active ingredient: Atorvastatin

Notice details →
Belgium

Magnesium Sulfate Sterop 2,5 g/5 ml inf. sol. (conc.) i.v. amp. 100 x 5 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Magnesium

Notice details →
Belgium

Mirtazapine AB 15 mg orodisp. tabl. 90

Available again · Not specified
Active ingredient: Mirtazapine

Notice details →
Belgium

Natribic 84 mg/ml inf. sol. (conc.) i.v. amp. 100 x 5 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Sodium Hydrogen Carbonate

Notice details →
Belgium

Phenobarbital Sodium Sterop 100 mg/1 ml inj. sol. i.v. amp. 10 x 1 ml

Nicht verfügbar · Delay in final product release
Active ingredient: Phenobarbital Sodium

Notice details →
Belgium

Physio Sterop 90 mg/10 ml parent. solv. i.v. amp. 10 x 10 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Sodium Chloride

Notice details →
Belgium

Physio Sterop 90 mg/10 ml parent. solv. i.v. amp. 100 x 10 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Sodium Chloride

Notice details →
Belgium

Procaine HCl Sterop 2% 100 mg/5 ml inj. sol. i.m./s.c. amp. 10 x 5 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Procaine Hydrochloride

Notice details →
Belgium

Procaine HCl Sterop 2% 100 mg/5 ml inj. sol. i.m./s.c. amp. 100 x 5 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Procaine Hydrochloride

Notice details →
Belgium

Tenofovir Disoproxil Viatris 245 mg film-coat. tabl. 30

Nicht verfügbar · Manufacturing delay
Active ingredient: Tenofovir Disoproxil

Notice details →
Belgium

Tigecycline Accord 50 mg inf. sol. (pwdr.) i.v. vial 10 x 50 mg

Nicht verfügbar · Manufacturing delay
Active ingredient: Tigecycline

Notice details →
Belgium

Vitamine B12 Sterop 1 mg/1 ml or. sol./inj. sol. i.m./i.v./s.c. amp. 100 x 1 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Cyanocobalamin

Notice details →
Belgium

Aacidexam 5 mg/ml inj. sol. i.m./i.v./i.burs./i.artic. amp. 10 x 1 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Dexamethasone

Notice details →
Belgium

Atorvastatin HCS 80 mg film-coat. tabl. 100

Available again · Not specified
Active ingredient: Atorvastatin

Notice details →
Belgium

Bisoprolol Viatris 2.5 mg film-coat. tabl. 30

Available again · Not specified
Active ingredient: Bisoprolol Fumarate

Notice details →
Belgium

Capecitabine Accord 500 mg film-coat. tabl. 120 (120 x 1) UD

Nicht verfügbar · Manufacturing delay
Active ingredient: Capecitabine

Notice details →
Belgium

Carboplatin Accord Healthcare 10 mg/ml inf. sol. (conc.) i.v. vial 15 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Carboplatin

Notice details →
Belgium

Carvedilol Sandoz 6.25 mg tabl. 100

Nicht verfügbar · Manufacturing delay
Active ingredient: Carvedilol

Notice details →
Belgium

Celecoxib KRKA 200 mg hard caps. 30

Available again · Not specified
Active ingredient: Celecoxib

Notice details →
Belgium

Celecoxib KRKA 200 mg hard caps. 60

Available again · Not specified
Active ingredient: Celecoxib

Notice details →
Belgium

Co-Lisinopril Sandoz 20 mg - 12.5 mg tabl. 98

Available again · Not specified
Active ingredient: Lisinopril,Hydrochlorothiazide

Notice details →
Belgium

Ebastine Sandoz 10 mg orodisp. tabl. 100

Nicht verfügbar · Manufacturing delay
Active ingredient: Ebastine

Notice details →
Belgium

Escitalopram Sandoz 10 mg film-coat. tabl. 100

Nicht verfügbar · Manufacturing delay
Active ingredient: Escitalopram

Notice details →
Belgium

Etoricoxib Krka 90 mg film-coat. tabl. 28

Available again · Not specified
Active ingredient: Etoricoxib

Notice details →
Belgium

Etoricoxib Krka 90 mg film-coat. tabl. 98

Available again · Not specified
Active ingredient: Etoricoxib

Notice details →
Belgium

Eusaprim 40 mg - 200 mg/5 ml or. susp. 100 ml

Available again · Not specified
Active ingredient: Sulfamethoxazole,Trimethoprim

Notice details →
Belgium

Flecainide Retard Sandoz 100 mg hard caps. prol.-rel. 100

Marketing ended · Commercial reasons
Active ingredient: Flecainide Acetate

Notice details →
Belgium

Flecainide Retard Sandoz 150 mg hard caps. prol.-rel. 100

Nicht verfügbar · Manufacturing delay
Active ingredient: Flecainide Acetate

Notice details →